AbbVie Inc.

ABBV ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $9.30B $5.10B $8.40B $8.35B $9.60B $5.90B $27.0M $10.0M
Accounts Receivable $5.09B
Inventory $1.61B $1.44B $1.72B $1.12B $1.15B $1.09B
Total Current Assets $21.22B $16.19B $16.31B $16.08B $17.85B $15.35B
Property, Plant & Equipment $2.80B $2.60B $2.57B $2.49B $2.30B $2.25B
Goodwill $15.79B $15.42B $13.17B $5.86B $6.28B $6.13B $6.10B
Intangible Assets (Excl. Goodwill) $27.56B $28.90B $19.71B $1.51B $1.89B $2.32B
Total Assets $70.79B $66.10B $53.05B $27.51B $29.20B $27.01B
Liabilities
Accounts Payable $1.47B $1.41B $1.60B $1.40B $933.0M $556.0M
Total Current Liabilities $16.64B $9.78B $10.89B $11.39B $6.88B $6.78B
Long-Term Debt
Total Liabilities $65.69B $61.46B $49.11B $25.77B $24.71B $27.36B
Stockholders' Equity
Retained Earnings $5.46B $4.38B $2.25B $535.0M $1.57B
Total Stockholders' Equity $5.10B $4.64B $3.95B $1.74B $4.49B $-350.0M
← Newer Page 2 of 2 Older →